Stockscreener 앱 받기
6.16
0.49%
0.03
시간 외 거래:
6.16
전일 마감가:
$6.13
열려 있는:
$6.09
하루 거래량:
140.48K
Relative Volume:
0.55
시가총액:
$167.75M
수익:
$331.52M
순이익/손실:
$-52.69M
주가수익비율:
-2.7378
EPS:
-2.25
순현금흐름:
$-14.47M
1주 성능:
+0.98%
1개월 성능:
+5.66%
6개월 성능:
-28.87%
1년 성능:
-17.65%
1일 변동 폭
$6.09
$6.21
1주일 범위
$6.00
$6.36
52주 변동 폭
$5.3401
$9.13
이노겐 Stock (INGN) Company Profile
명칭
Inogen Inc
전화
805-562-0500
주소
500 CUMMINGS CENTER, BEVERLY, CA
Compare INGN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
6.16 | 166.93M | 331.52M | -52.69M | -14.47M | -2.25 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
이노겐 Stock (INGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-16 | 개시 | B. Riley Securities | Buy |
| 2025-05-22 | 업그레이드 | Needham | Hold → Buy |
| 2024-02-15 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-07-14 | 다운그레이드 | Needham | Buy → Hold |
| 2023-01-17 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | 업그레이드 | Needham | Hold → Buy |
| 2021-11-02 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-08-05 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | 다운그레이드 | Needham | Buy → Hold |
| 2020-05-06 | 재확인 | Needham | Buy |
| 2019-11-06 | 업그레이드 | Needham | Hold → Buy |
| 2019-09-13 | 재확인 | Piper Jaffray | Overweight |
| 2019-08-08 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-08-07 | 다운그레이드 | Needham | Buy → Hold |
| 2019-06-28 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-05-08 | 재확인 | Needham | Strong Buy |
| 2019-02-27 | 재확인 | Needham | Strong Buy |
| 2018-11-20 | 업그레이드 | Needham | Buy → Strong Buy |
| 2018-11-07 | 재확인 | Needham | Buy |
| 2018-09-10 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2018-08-22 | 재개 | Stifel | Buy |
| 2018-08-08 | 재확인 | Needham | Strong Buy |
| 2018-06-06 | 개시 | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | 재확인 | Needham | Strong Buy |
| 2018-02-28 | 재확인 | Needham | Strong Buy |
모두보기
이노겐 주식(INGN)의 최신 뉴스
Inogen Inc Stock (ISIN: US45780L1044) Faces Headwinds Amid Portable Oxygen Slowdown - AD HOC NEWS
Aug Outlook: Is Inogen Inc likely to announce a buybackWeekly Profit Recap & Verified Chart Pattern Trade Signals - baoquankhu1.vn
CSM Advisors LLC Buys Shares of 364,100 Inogen, Inc $INGN - MarketBeat
Inogen, Inc $INGN Shares Sold by Divisadero Street Capital Management LP - MarketBeat
What Is Behind Rising Interest In Inogen Respiratory Care Technology? - Kalkine Media
Short Interest in Inogen, Inc (NASDAQ:INGN) Expands By 24.2% - MarketBeat
Earnings Update: Is Inogen Inc forming bullish engulfing patterns2026 Growth vs Value & Technical Confirmation Alerts - baoquankhu1.vn
Inogen Inc expected to post a loss of 27 cents a shareEarnings Preview - TradingView
Inogen (NASDAQ:INGN) Stock Price Crosses Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Here's why you should add Inogen stock to your portfolio now - MSN
Exit Recap: What are the risks of holding Inogen IncJuly 2025 Final Week & AI Enhanced Trading Signals - baoquankhu1.vn
Earnings Beat: Is Inogen Inc a turnaround storyJuly 2025 Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
Inogen Announces Participation in the KeyBanc Virtual Life Sciences & MedTech Investor Forum - The AI Journal
Comparing Neuronetics (NASDAQ:STIM) & Inogen (NASDAQ:INGN) - Defense World
Inogen, Inc (NASDAQ:INGN) Short Interest Update - MarketBeat
Inogen Earnings Call Shows Turnaround Amid Mixed Headwinds - The Globe and Mail
[Form 4] Inogen Inc Insider Trading Activity - Stock Titan
Inogen (NASDAQ: INGN) EVP reports RSU grant, vesting and tax disposals - Stock Titan
Inogen (INGN) CCO reports RSU vesting and 20,000-unit grant - Stock Titan
Inogen (INGN) EVP Kevin P. Smith reports RSU grants and tax share withholding - Stock Titan
Inogen (NASDAQ: INGN) CFO logs RSU vesting, share tax withholdings - Stock Titan
Inogen (INGN) CEO receives 90,000 RSU grant and reports tax share withholdings - Stock Titan
INGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Revenue Check: Whats the beta of Inogen Inc stock2025 Retail Activity & Growth Focused Investment Plans - baoquankhu1.vn
What’s the beta of Inogen Inc. stock2025 Price Momentum & Daily Price Action Insights - mfd.ru
Inogen (NASDAQ: INGN) outlines 2025 revenue mix and respiratory growth strategy - Stock Titan
Inogen, Inc. (NASDAQ:INGN) Q4 2025 Earnings Call Transcript - Insider Monkey
Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y - sharewise.com
Risk Report: How do insiders feel about Inogen IncWeekly Trade Analysis & Risk Controlled Daily Plans - baoquankhu1.vn
Celebrating 25 Years of Inogen Alliance: A Milestone in Global EHS & Sustainability Leadership - Morningstar
Portfolio Update: Does Inogen Inc have pricing powerPortfolio Profit Report & Low Drawdown Momentum Ideas - baoquankhu1.vn
Inogen, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Inogen authorizes $30 million stock buyback program - Investing.com India
Inogen GAAP net loss hits USD 7.1M in Q4 2025 - Medical Buyer
Inogen Announces $30 Million Share Repurchase Program - BioSpace
Inogen Inc earnings beat by $0.07, revenue fell short of estimates - Investing.com India
Inogen Inc (INGN) Q4 2025 Earnings Call Highlights: Revenue Grow - GuruFocus
Inogen Q4 Earnings Call Highlights - MarketBeat
Inogen (INGN) Projects Revenue Growth in 2026 Forecast - GuruFocus
Inogen (INGN) Projects Flat Revenue for Q1 2026 - GuruFocus
Inogen authorizes $30 million stock buyback program By Investing.com - Investing.com Australia
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Inogen (INGN) Reports Growth with Positive EBITDA in Q4 - GuruFocus
Inogen Inc (NASDAQ:INGN) Stock Falls on Revenue Miss and Cautious 2026 Outlook - ChartMill
Inogen (INGN) Initiates $30 Million Share Buyback Program - GuruFocus
Inogen, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:INGN) 2026-02-24 - Seeking Alpha
Inogen: Q4 Earnings Snapshot - Barchart.com
Inogen Posts 2025 Results and Launches Share Buyback - TipRanks
Inogen Q4 revenue rises - TradingView
Inogen (NASDAQ:INGN) Releases Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
Inogen : Supplemental Financials FY 2025 - marketscreener.com
이노겐 (INGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
이노겐 주식 (INGN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Yi Boyer Jennifer M | EVP Entrprs Enblmnt, Ch HR Off |
Mar 01 '26 |
Option Exercise |
0.00 |
25,017 |
0 |
33,699 |
| Ramade Gregoire | Chief Commercial Officer |
Mar 01 '26 |
Option Exercise |
0.00 |
13,005 |
0 |
50,251 |
| Smith Kevin P. | EVP, Bus Dev, GC & Sec |
Mar 01 '26 |
Option Exercise |
0.00 |
14,005 |
0 |
28,283 |
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 01 '26 |
Option Exercise |
0.00 |
42,007 |
0 |
100,949 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '26 |
Option Exercise |
0.00 |
58,346 |
0 |
147,973 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '25 |
Option Exercise |
0.00 |
31,566 |
0 |
50,189 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '25 |
Option Exercise |
0.00 |
28,334 |
0 |
100,108 |
| Smith Kevin P. | EVP, Bus Dev, GC & Sec |
Sep 01 '25 |
Option Exercise |
0.00 |
18,135 |
0 |
20,821 |
0.85%
1.86%
자본화:
|
볼륨(24시간):